Cargando…
Transplantation of a Liver Allograft From a Hepatitis C Virus Seropositive Donor With Previous Sustained Virologic Response to an Uninfected Recipient Suffering Steroid Refractory Acute Graft Rejection With No Evidence of HCV Transmission
BACKGROUND: The goal of treating chronic hepatitis C virus (HCV) infection is sustained virologic response (SVR). There is concern that despite achieving SVR, replication-competent HCV may be sequestered at low levels within the liver and could theoretically reactivate with immunosuppression. We rep...
Autores principales: | Mitchell, Robert A., Hussaini, Trana, Yau, Alan H., Krajden, Mel, Wright, Alissa J., Scudamore, Charles H., Marquez Azalgara, Vladimir, Erb, Siegfried R., Yoshida, Eric M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912017/ https://www.ncbi.nlm.nih.gov/pubmed/29707618 http://dx.doi.org/10.1097/TXD.0000000000000763 |
Ejemplares similares
-
Early Persistent Progressive Acute Kidney Injury and Graft Failure Post Liver Transplantation
por: Hussaini, Trana, et al.
Publicado: (2019) -
Successful Liver Transplantation in a Patient With Acute COVID-19 Infection and Acute Liver Failure: A Case Report
por: Kidson, Kristen M., et al.
Publicado: (2021) -
Acute Antibody-mediated Rejection Coexisting With T Cell–mediated Rejection in Pediatric ABO-incompatible Transplantation
por: Yanagi, Yusuke, et al.
Publicado: (2022) -
The Role of Dynamic DNA Methylation in Liver Transplant Rejection in Children
por: Ningappa, Mylarappa, et al.
Publicado: (2022) -
Belatacept Treatment of Recurrent Late-onset T Cell–mediated Rejection/Antibody-mediated Rejection With De Novo Donor-specific Antibodies in a Liver Transplant Patient
por: Klintmalm, Göran B., et al.
Publicado: (2022)